Benefits
Stress adaptation and cortisol regulation
Multiple clinical studies show holy basil reduces cortisol levels, cognitive performance impairment during stress, and subjective stress/anxiety scores. Ocimumosides A and B directly modulate HPA axis cortisol output.
Cognitive function
RCT in healthy adults showed significant improvements in attention, short-term memory, and sensorimotor performance after 30 days of holy basil extract.
Blood sugar regulation
Multiple clinical studies in diabetic patients show holy basil leaf powder reduces fasting glucose, postprandial glucose, and HbA1c. Mechanism involves alpha-glucosidase inhibition and insulin secretagogue activity.
Anti-inflammatory and antimicrobial
Eugenol inhibits COX-1/2 enzymes comparable to aspirin. Tulsi extracts show broad-spectrum antimicrobial activity against common respiratory pathogens.
Mechanism of action
HPA axis modulation
Ocimumosides A and B interact with corticosteroid receptors and modulate HPA axis feedback sensitivity, reducing ACTH-stimulated cortisol secretion during stress.
COX and 5-LOX inhibition
Eugenol and ursolic acid inhibit both cyclooxygenase (COX-1 and COX-2) and 5-lipoxygenase pathways, providing dual anti-inflammatory action reducing both prostaglandin and leukotriene production.
Alpha-glucosidase and alpha-amylase inhibition
Holy basil phenolic compounds inhibit intestinal carbohydrate-digesting enzymes, slowing glucose absorption from meals and reducing postprandial glucose spikes.
Clinical trials
Randomized controlled trial of Ocimum tenuiflorum (formerly O. sanctum) extract (300 mg/day) vs placebo in 71 healthy adults for 30 days. Outcomes: reaction time, attention measures, error rate, cognitive flexibility, subjective stress. (Sampath et al. 2015, Pharmacognosy Mag)
71 healthy adults. 30-day intervention.
Modest improvements in reaction time, error rate, cognitive flexibility, and subjective stress measures vs placebo. Effect sizes small; single trial. Note: holy basil is positioned as an adaptogen with cognitive and stress-reducing applications; evidence base is modest.
Randomized crossover trial of holy basil leaf powder (2.5 g/day) vs placebo in 40 patients with mild non-insulin-dependent diabetes for 4 weeks each. Outcomes: fasting glucose, postprandial glucose, urinary glucose. (Agrawal et al. 1996, Int J Clin Pharmacol Ther)
40 mild T2DM patients.
Fasting glucose reduced ~17.6% and postprandial glucose ~7.3% in tulsi period vs placebo. Urinary glucose also reduced. Modest effects; adjunctive to standard diabetes management. Older trial; modern T2DM care has multiple effective pharmaceutical options.